Ahmed, Ossama A <br/><br/>
Outcomes of Treatment and Predictors of Response to Sofosbuvir Plus Simeprevir in Hepatitis C Virus with Genotype-4 Infection.  [electronic resource] 

 -  Infectious disorders drug targets  2020 
 - 389-395 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>2212-3989 
<br/><br/><label>Standard No.: </label>10.2174/1871526519666181218104600  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antiviral Agents--therapeutic use<br/>Drug Therapy, Combination<br/>Egypt<br/>Female<br/>Genotype<br/>Hepacivirus--classification<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>RNA, Viral--genetics<br/>Simeprevir--therapeutic use<br/>Sofosbuvir--therapeutic use<br/>Sustained Virologic Response<br/>Treatment Outcome<br/>Young Adult